OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
ACTH(4-7)-Pro-Gly-Pro. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 200 mcg | 1–2× daily | 0.12 mL | 12 u | 25 doses | |
| Standard | 400 mcg | 1–2× daily | 0.24 mL | 24 u | 12 doses | |
| Upper reported | 600 mcg | 1–2× daily | 0.36 mL | 36 u | 8 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 200 mcg | daily | 0.12 mL | 12 u | 14 | 2.8 mg |
| Weeks 3–4 | 400 mcg | daily | 0.24 mL | 24 u | 14 | 5.6 mg |
| Week 5 onward per 4 weeks from here on |
600 mcg | daily | 0.36 mL | 36 u | 28 | 16.8 mg |
A synthetic ACTH fragment analogue registered as a medicine in Russia for stroke and cognitive indications. Substantial Russian clinical literature; almost no Western replication.
Buy Semaxthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
The principal endogenous intracellular antioxidant tripeptide. Widely administered in clinical settings; the evidence for parenter…
A tuftsin-derived heptapeptide registered in Russia as an anxiolytic. Reported to modulate GABAergic and enkephalin systems withou…
Every compound compared in one table: dose range, how often, half-life and evidence tier.